Schaeffers Research
18 Feb 2026, 15:16 UTC · 30w ago
Verdict
Headline takes no side. We score MRNA +0.70 — strongly bullish.
+0.70strongly bullish
More positive than 77% of ticker scores this week
Which stocks this story touches
More positive than 77% of ticker scores this week
FDA acceptance of Moderna's flu vaccine application for review is a positive regulatory step, driving a 5.7% stock gain and building on a strong year-to-date rally.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
3d ago
+250.6%
Price agrees with the score
$154.04 vs $43.93 close before publication (Feb 17) · not market-adjusted
MRNA chart →
